Quick Takeaways
- BlackRock, Inc. filed SCHEDULE 13G/A for Tenaya Therapeutics, Inc Common Stock (TNYA).
- Disclosed ownership: 6.7%.
- Date of event: 31 Dec 2024.
BlackRock, Inc. - 31 Dec 2024 SCHEDULE 13G/A Report for Tenaya Therapeutics, Inc Common Stock (TNYA)
- Filing Manager
- BlackRock, Inc.
- Reporting Manager
- BlackRock, Inc.
- Symbol
- TNYA
- Shares outstanding
- 79,051,881 shares
- Disclosed Ownership
- 5,296,476 shares
- Ownership
- 6.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 05 Feb 2025, 13:23:37 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 16 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BlackRock, Inc. disclosed 6.7% ownership in Tenaya Therapeutics, Inc Common Stock (TNYA) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Feb 2025, 13:23.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 6.7% | 5,296,476 | 5,239,827 | 0 | Spencer Fleming | Managing Director |